Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial

  • Ron Brazg
  • , Satish K. Garg
  • , Anuj Bhargava
  • , James R. Thrasher
  • , Kashif Latif
  • , Bruce W. Bode
  • , Timothy S. Bailey
  • , Barry S. Horowitz
  • , Arvind Cavale
  • , Yogish C. Kudva
  • , Kevin B. Kaiserman
  • , George Grunberger
  • , John Chip Reed
  • , Sarnath Chattaraj
  • , Gina Zhang
  • , John Shin
  • , Vivian Chen
  • , Scott W. Lee
  • , Toni L. Cordero
  • , Andrew S. Rhinehart
  • Robert A. Vigersky, Bruce A. Buckingham

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)535-543
Number of pages9
JournalDiabetes Technology and Therapeutics
Volume24
Issue number8
DOIs
StatePublished - Aug 1 2022
Externally publishedYes

ASJC Scopus Subject Areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Keywords

  • Adults
  • Failure rate
  • Insulin infusion set
  • Survival rate
  • Time in range
  • Unexplained hyperglycemia

Cite this